Maven Securities’s iShares Biotechnology ETF IBB Stock Holding History

Maven Securities’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,014	Closed	-$761K	–	626
2025 Q2	$761K	Buy	+6,014	New	+$738K	0.02%	502
2024 Q4	–	Sell	-15,363	Closed	-$2.24M	–	913
2024 Q3	$2.24M	Buy	+15,363	New	+$2.22M	0.04%	327
2024 Q2	–	Sell	-11,443	Closed	-$1.57M	–	952
2024 Q1	$1.57M	Sell	11,443 -742	-6%	-$101K	0.09%	102
2023 Q4	$1.66M	Buy	+12,185	New	+$1.49M	0.03%	355
2022 Q3	–	Sell	-31,106	Closed	-$3.66M	–	1156
2022 Q2	$3.66M	Buy	+31,106	New	+$3.69M	0.11%	136
2021 Q1	–	Sell	-4,771	Closed	-$727K	–	1224
2020 Q4	$727K	Sell	4,771 -8,742	-65%	-$1.25M	0.07%	294
2020 Q3	$1.84M	Buy	+13,513	New	+$1.83M	0.15%	138
2020 Q2	–	Sell	-11,997	Closed	-$1.29M	–	539
2020 Q1	$1.29M	Buy	+11,997	New	+$1.38M	0.15%	95

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Maven Securities's IBB Position: Q3 2025 in Review

Maven Securities sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 6,014 shares — an estimated $761K sold.

Maven Securities first reported a position in IBB in Q1 2020 and held it in 8 quarters. The position peaked at $3.66M in Q2 2022. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

Maven Securities reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
Maven Securities sold 6,014 iShares Biotechnology ETF shares in Q3 2025, an estimated $761K.
Maven Securities first reported a position in iShares Biotechnology ETF in Q1 2020 and held it in 8 quarters.
Maven Securities's iShares Biotechnology ETF position peaked at $3.66M in Q2 2022.
803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Maven Securities's 13F filing for Q3 2025, filed 20 Nov 2025.